Aquablation in Benign Prostatic Hyperplasia in Canada

Can-Am HIFU

Status: Enrolling

Conditions: Urologic Diseases

Treatments: Procedure: Aquablation

Study type: Observational

Funder types: Other

Identifiers

NCT05169892

Aquablation in BPH

Details and patient eligibility

About

To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.

Full description

Patients will be followed up for 3 years as standard of care.

Enrollment: 25 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary diagnosis of Benign Prostate Hypertrophy (BPH)
• Male subjects of ≥ 18 years of age
• Candidate for Aquablation therapy as per clinical decision of Investigator
• Willing and able to accurately complete questionnaires
• Willing and able to provide signed and dated informed consent

Exclusion criteria

• Characteristics indicating a poor compliance with study protocol requirements.
• Disease or other health condition that is not suitable for this study.
• Unable or unwilling to provide signed informed consent.

Trial design

25 participants in 1 patient group

Aquablation

Treatment:

Procedure: Aquablation